Page last updated: 2024-08-24

fluorodeoxyglucose f18 and dihydroxyphenylalanine

fluorodeoxyglucose f18 has been researched along with dihydroxyphenylalanine in 143 studies

Research

Studies (143)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (0.70)	18.7374
1990's	23 (16.08)	18.2507
2000's	43 (30.07)	29.6817
2010's	66 (46.15)	24.3611
2020's	10 (6.99)	2.80

Authors

Authors	Studies
Fukumura, T; Goto, I; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Shima, F	1
Heiss, WD; Herholz, K; Holthoff, V; Huber, M; Karbe, H; Wagner, R; Wienhard, K	1
Hatazawa, J; Ido, T; Ishiwata, K; Itoh, M; Matsumoto, M; Mejia, AA; Nakamura, T; Seo, S; Watabe, H; Watanuki, S	1
Calne, DB; Eisen, A; Meneilly, G	1
Fowler, JS; Wolf, AP	1
Cedarbaum, J; Dhawan, V; Eidelberg, D; Fahn, S; Ginos, JZ; Greene, P; Moeller, JR; Rottenberg, DA; Sidtis, JJ; Strother, SC	1
Adam, MJ; Ammann, W; Bergstrom, M; Harrop, R; Laihinen, A; Martin, WR; Rogers, JG; Ruth, TJ; Sayre, CI; Stoessl, AJ	1
Antonini, A; Günther, I; Leenders, KL; Maguire, PR; Missimer, J; Psylla, M; Vontobel, P	1
Lang, AE	1
Chaly, T; Dhawan, V; Eidelberg, D; Fahn, S; Giladi, N; Ishikawa, T; Przedborski, S; Spetsieris, P; Takikawa, S	1
Akashi, Y; Fukumura, T; Goto, I; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Yoshida, T	1
Fink, G; Heiss, WD; Herholz, K; Jacobs, A; Mielke, R; Pietrzyk, U; Slansky, I; Würker, M	1
Antonini, A; Boecker, H; Conrad, B; Grafin von Einsiedel, H; Kruggel, F; Kuwert, T; Leenders, K; Weindl, A	1
Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S	1
Barrio, JR; Bida, G; Bishop, A; Satyamurthy, N	1
Akiguchi, I; Fukuyama, H; Hanakawa, T; Kato, M; Kimura, J; Shibasaki, H	1
Heiss, WD; Herholz, K; Lanfermann, H; Pietrzyk, U; Thiel, A; Wagner, R; Wienhard, K	1
Brooks, DJ; Morrish, PK; Sawle, GV	1
Fukumura, T; Hosokawa, S; Ichiya, Y; Kato, M; Kuwabara, Y; Masuda, K; Otsuka, M; Sasaki, M; Yoshida, T	1
Fujiwara, T; Itoh, M; Meguro, K; Yamadori, A; Yamaguchi, S	1
Antonini, A; Günther, I; Leenders, KL; Maguire, RP; Missimer, J; Psylla, M; Vontobel, P	1
Barlogie, B; Dhodapkar, M; Eidelberg, D; Harik, SI; Rudnicki, SA	1
Antonini, A; Chokroverty, S; Dhawan, V; Eidelberg, D; Hening, WA; Trenkwalder, C; Walters, AS	1
Degueldre, C; Franck, G; Garraux, G; Laureys, S; Lemaire, C; Peigneux, P; Salmon, E	1
Imahori, Y; Kawano, H; Misawa, A; Sawada, T; Takeuchi, Y	1
Bamborschke, S; Ghaemi, M; Heiss, WD; Rudolf, J; Schmülling, S	1
Altehoefer, C; Brink, I; Ghanem, N; Hoegerle, S; Moser, E; Nitzsche, E	1
Burger, C; Dimitrakopoulou-Strauss, A; Strauss, LG	1
Graham, MM	1
Altehoefer, C; Ghanem, N; Hoegerle, S; Koehler, G; Moser, E; Nitzsche, E; Scheruebl, H; Waller, CF	1
Beckmann, H; Ellitok, E; Gerhard, A; Lauer, M; Reske, SN; Schirrmeister, H; Stöber, G	1
Jankovic, J; Kapadia, AS	1
Hisanaga, K; Iwasaki, Y; Jin, K; Mochizuki, H; Sato, N; Suzuki, H; Tanji, H	1
Brooks, DJ; Ceravolo, R; de Yebenez, J; Lees, AJ; Piccini, P; Pramstaller, P; Turjanski, N	1
Deuschl, G; Ghaemi, M; Heiss, WD; Hilker, R; Raethjen, J; Rudolf, J; Sobesky, J	1
Aide, N; Balogova, S; Colombet, C; De Beco, V; Grahek, D; Jacob, T; Kerrou, K; Montravers, F; Talbot, JN; Younsi, N	1
Abe, Y; Arahata, Y; Dagher, A; Hatano, K; Ito, K; Iwai, K; Kachi, T; Kato, T; Kawasumi, Y; Nagano-Saito, A; Nakamura, A; Washimi, Y; Yamada, T	1
Ahlskog, JE; Albin, RL; Brooks, DJ; Carbon, M; Dhawan, V; Eidelberg, D; Fahn, S; Feigin, A; Guttman, M; Gwinn-Hardy, K; Holloway, R; Innis, R; Katz, RG; Kieburtz, K; Kish, SJ; Lange, N; Langston, JW; Marek, K; McFarland, H; Morin, L; Moy, C; Murphy, D; Oertel, WH; Oliver, G; Palesch, Y; Powers, W; Ravina, B; Seibyl, J; Sethi, KD; Sheehy, P; Shults, CW; Stoessl, AJ	1
Bley, TA; Brink, I; Hoegerle, S; Klisch, J	1
Chang, CP; Chu, YK; Hsieh, HJ; Lin, SH; Wang, SJ	1
Hundemer, HP; Kaasinen, V; Leenders, KL; Maguire, RP	1
Fogelman, I; Heinisch, M; Langsteger, W	1
Balan, K; Seshadri, N; Wat, J	1
Balash, Y; Bartels, AL; de Jong, BM; Giladi, N; Leenders, KL; Maguire, RP; Pruim, J; Schaafsma, JD; Veenma, L; Youdim, MB	1
Chen, W; Cloughesy, T; Czernin, J; Delaloye, S; Kamdar, N; Pope, W; Satyamurthy, N; Schiepers, C; Silverman, DH	1
Montandon, ML; Ruest, T; Schoenahl, F; Zaidi, H	1
Fanti, S; Nanni, C; Rubello, D	1
de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; van der Horst-Schrivers, AN	1
Gault, N; Grahek, D; Gutman, F; Kerrou, K; Montravers, F; Schlienger, M; Talbot, JN; Touboul, E	1
Beuthien-Baumann, B; Bredow, J; Kotzerke, J; Strumpf, A; Zessin, J	1
Ell, PJ; Groves, AM; Haim, SB; Win, T	1
Balan, KK; Brown, MJ; Chatterjee, K; Gurnell, M; Mackenzie, IS; Simpson, H	1
Vallabhajosula, S	1
Biraben, A; Bouilleret, V; Chassoux, F; Mantzaridez, M; Ribeiro, MJ; Semah, F; Trebossen, R	1
Bentho, O; Conant, S; Eldadah, BA; Goldstein, DS; Holmes, C; Imrich, R; Moak, J; Sato, T; Sharabi, Y	1
Brouwers, AH; de Vries, EG; Elsinga, PH; Jager, PL; Kema, IP; Koopmans, KP; Neels, OC; Sluiter, WJ; Vanghillewe, K	1
Barlier, A; Colavolpe, C; De Micco, C; Henry, JF; Morange, I; Mundler, O; Niccoli-Sire, P; Palazzo, FF; Sebag, F; Taïeb, D; Tessonnier, L	1
Arbizu Lostao, J; Azcona San Julián, C; Carracedo, A; Fernández-Marmiesse, A; Garrastachu Zumarrán, P; Martino Casado, E; Richter Echevarría, JA	1
Fischman, AJ	1
Brouwers, AH; de Vries, EG; Fiebrich, HB; Links, TP	1
Bouchard, P; Duron, F; Grangé, JD; Houry, S; Huchet, V; Kerrou, K; Lotz, JP; Montravers, F; Nataf, V; Rougier, P; Ruszniewski, P; Talbot, JN	1
Beheshti, M; Broinger, G; Dralle, H; Kohlfürst, S; Langsteger, W; Nader, M; Pirich, C; Pöcher, S; Vali, R; Waldenberger, P	1
Tenenbaum, F	1
Brouwers, AH; de Vries, EG; Fiebrich, HB; Koopmans, KP	1
Adams, KT; Carrasquillo, JA; Chen, CC; Eisenhofer, G; Havekes, B; Ling, A; Martiniova, L; Pacak, K; Timmers, HJ; Whatley, M	1
D'Souza, M; Garg, G; Jaimini, A; Khurana, A; Mishra, A; Mondal, A; Sharma, R; Tripathi, M; Varshney, R	1
Demjaha, A; Egerton, A; Howes, OD; McGuire, P; Mehta, MA	1
Dudczak, R; Traub-Weidinger, T	1
Al-Nahhas, A; Ambrosini, V; Fanti, S; Ferdeghini, M; Gross, MD; Marzola, MC; Massaro, A; Pelizzo, MR; Rubello, D; Toniato, A	1
Alexopoulos, DK; Chen, CC; Jacobs, S; King, KS; Mattox, DE; Pacak, K; Reynolds, JC; Whatley, MA	1
D'Souza, M; Datta, A; Garg, G; Grover, RK; Jaimini, A; Kumar, N; Mishra, AK; Mondal, A; Panwar, P; Sharma, R; Singh, D; Tripathi, M; Varshney, R	1
Baudrexel, S; Diederich, NJ; Eggers, C; Heiss, WD; Hilker, R; Hohmann, C; Kalbe, E; Klein, JC; Vollmar, S; Weisenbach, S	1
Chew, SL	1
Chabrier, G; Detour, J; Goichot, B; Greget, M; Imperiale, A; Keomany, J; Pessaux, P; Rust, E	1
Bressman, S; Brüggemann, N; Condefer, K; Dhawan, V; Hagenah, J; Klein, C; Kornreich, R; Ozelius, L; Palmese, C; Pastores, G; Roe, A; Sathe, S; Saunders-Pullman, R; Stanley, K; Tagliati, M	1
Schwarz, J	1
Benz, MR; Bockisch, A; Czernin, J; Damoiseaux, RD; Hartung, V; Hildebrandt, IJ; Laing, RE; Phelps, ME; Walter, MA; Weber, WA	1
Karges, W; Mottaghy, FM; Van Binnebeek, S	1
Beer, AJ; Buck, AK; Eckel, F; Herrmann, K	1
Adams, KT; Alexopoulos, DK; Chen, CC; King, KS; Lando, H; Ling, A; Pacak, K; Patronas, N; Reynolds, JC; Stratakis, CA; Whatley, MA; Xekouki, P	1
Ahonen, A; Arola, J; Ebeling, T; Heiskanen, I; Kajander, S; Kauhanen, S; Korsoff, P; Lisinen, I; Minn, H; Nuutila, P; Sane, T; Schalin-Jäntti, C; Schildt, J; Seppänen, M; Väisänen, M; Välimäki, MJ; Virtanen, S	1
Ambrosini, V; Castaldi, P; Cremonini, N; de Waure, C; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Santimaria, M; Treglia, G; Versari, A; Villani, MF	1
Apers, JA; de Heide, LJ; Glaudemans, AW; Oomen, PH; Totté, ER; van Beek, AP	1
Chowdhury, FU; Gross, MD; Marzola, MC; Rubello, D; Scarsbrook, AF; Waterfield, RT; Wong, KK	1
Gallowitsch, HJ; Malle, P; Sorschag, M	1
Goichot, B; Hubele, F; Imperiale, A; Rust, E; Taieb, D; Taquet, MC; Veillon, F	1
Calabria, F; Schillaci, O	1
Ambrosini, V; Castaldi, P; Cremonini, N; Fanti, S; Filice, A; Giordano, A; Perotti, G; Rufini, V; Treglia, G; Versari, A; Villani, MF	1
Brouwers, AH; de Groot, JW; Hofstra, RM; Koopmans, KP; Links, TP; Muller Kobold, AC; Plukker, JT; van der Horst-Schrivers, AN; Verbeek, HH	1
Benecke, A; Copeland, C; Howes, OD; Lingford-Hughes, AR; Mehta, MA; Shotbolt, P; Stokes, PR; Turkheimer, E; Turkheimer, FE	1
Chang, HH; Hsu, WM; Huang, SF; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, MY; Luo, TY; Shen, LH; Tzen, KY; Wu, PY; Yang, YL	1
Balogova, S; Huchet, V; Kerrou, K; Michaud, L; Montravers, F; Nataf, V; Talbot, JN	1
Cascini, GL; Cuccurullo, V; Mansi, L; Rotondo, A; Tamburrini, O	1
Cabria, M; Cistaro, A; Conte, M; Fanti, S; Foppiani, L; Garaventa, A; Lopci, E; Piccardo, A; Villavecchia, G	1
Cardillo, G; Di Franco, D; Enang, GN; Giordano, A; Rufini, V; Stefanelli, A; Treglia, G	1
Bal, C; Bandopadhyaya, GP; Gupta, DK; Karunanithi, S; Khangembam, BC; Kumar, A; Kumar, R; Malhotra, A; Sharma, P	1
Balogova, S; Kaliska, L; Kunikowska, J; Montravers, F; Slavikova, K; Talbot, JN; Treglia, G; Vereb, M	1
Chevallier, P; Legmann, P; Prat, F; Taieb, D; Tenenbaum, F	1
Warner, RR; Zanzi, I	1
Blanchet, EM; Chen, CC; Herscovitch, P; Martucci, V; Millo, C; Pacak, K	1
Blanchet, EM; Bluemke, DA; Maass-Moreno, R; Martucci, V; Millo, C; Pacak, K	1
Benz, MR; Buck, AK; Chen, W; Cloughesy, T; Czernin, J; Herrmann, K; Lai, A; Phelps, ME; Pomykala, KL	1
Eggers, C; Kracht, L; Pedrosa, DJ; Schwartz, F; Timmermann, L	1
Pacak, K; Shulkin, BL; Taïeb, D; Timmers, HJ	1
Xie, T; Zaidi, H	1
Santhanam, P; Taïeb, D	1
Evangelista, L; Farsad, M; Pelizzo, MR; Piotto, A	1
Carney, JA; Chen, CC; Papadakis, GZ; Patronas, NJ; Stratakis, CA	1
Capriotti, G; Pagani, M; Sonni, I	1
Acevedo-Báñez, I; García-Gómez, FJ; Mangas-Cruz, MA; Muñiz-Grijalvo, O; Tirado-Hospital, JL	1
Acevedo-Báñez, I; Álvarez-Pérez, RM; Borrego-Dorado, I; Cuenca-Cuenca, JI; García-Gómez, FJ; García-Jiménez, R; García-Morillo, JS; Martínez-Castillo, R; Pachón-Garrudo, VM; Rivas-Infante, E; Tirado-Hospital, JL	1
Kumar, A; Kumar, R; Shamim, SA	1
Carapella, CM; Chiaravalloti, A; Fabi, A; Floris, R; Marzi, S; Pace, A; Piludu, F; Schillaci, O; Terrenato, I; Vidiri, A; Villani, V	1
Cama, A; Garrè, ML; Mascelli, S; Massollo, M; Milanaccio, C; Morana, G; Nozza, P; Piccardo, A; Puntoni, M; Raso, A; Rossi, A	1
Bernard Ir, C; Hustinx, R; Salmon, E	1
de Labriolle-Vaylet, C; Jehanno, N; Michon, J; Montravers, F; Wartski, M	1
Adams, KT; Buchmann, I; Chen, CC; Fojo, AT; Herscovitch, P; Janssen, I; Kebebew, E; Millo, CM; Nambuba, J; Pacak, K; Patronas, NJ; Sadowski, SM; Taieb, D	1
Beuthien-Baumann, B; Kotzerke, J; Löhle, M; Mende, J; Oehme, L; Reichmann, H; Storch, A; van den Hoff, J; Wolz, M	1
Cabria, M; Garrè, ML; Morana, G; Piccardo, A; Rossi, A	1
Chang, HH; Hsu, WM; Huang, SF; Jeng, YM; Jou, ST; Lee, H; Lee, YL; Liao, YF; Lin, DT; Lin, KH; Liu, YL; Lu, CC; Lu, MY; Miser, JS; Tzen, KY; Yang, YL	1
Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P	1
Giovanella, L; July, M; Santhanam, P; Treglia, G	1
Ebbehoj, A; Gormsen, LC; Poulsen, PL; Søndergaard, E	1
Chang, HH; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Liu, CJ; Liu, YL; Lu, MY; Tzen, KY; Yang, YL; Yen, RF	1
Cuccurullo, V; Di Stasio, GD; Mansi, L; Prisco, MR	1
He, Q; Shi, X; Wang, X; Zhang, B; Zhang, X	1
Barker, RA; Foltynie, T; Lao-Kaim, NP; Li, W; Loane, C; Martín-Bastida, A; Paul, G; Piccini, P; Politis, M; Roussakis, AA; Valle-Guzman, N; Widner, H	1
Carideo, L; Cicone, F; Minniti, G; Scopinaro, F	1
Cuccurullo, V; Di Stasio, GD; Mansi, L	1
Arcolin, M; Bertoldo, A; Dipasquale, O; Expert, P; Fisher, PM; Howes, O; Khan, W; Moro, L; Rizzo, G; Svarer, C; Turkheimer, FE; Veronese, M	1
Ansquer, C; Bera, G; Bergeret, S; Chanson, P; Charbit, J; Lussey-Lepoutre, C	1
Ansquer, C; Drui, D; Kraeber-Bodéré, F; Lugat, A; Mirallié, E	1
Hoberück, S; Kotzerke, J; Martino, F; Michler, E; Platzek, I	1
Drzezga, A; Eggers, C; Greuel, A; Hammes, J; Maier, F; Ruppert, MC; Schwartz, F; Stürmer, S; Tahmasian, M; Timmermann, L; Tittgemeyer, M; van Eimeren, T	1
Bozzao, A; Carideo, L; Cicone, F; Minniti, G; Scaringi, C; Scopinaro, F; Villani, V	1
Arabi, H; Bortolin, K; Garibotto, V; Ginovart, N; Zaidi, H	1
Eggers, C; Eidelberg, D; Fink, GR; Holtbernd, F; Ma, Y; Oh, A; Spetsieris, P; Tang, CC; Timmermann, L	1
Dhomps, A; Galan, A; Jacquet-Francillon, N; Passot, G; Tordo, J	1
Cottereau, AS; Dousset, B; Garcia, C; Libe, R; Tenenbaum, F	1
Chang, HH; Chou, SW; Hsu, WM; Jou, ST; Ko, CL; Ko, KY; Lu, MY; Yang, YL; Yen, RF	1
Bund, C; Chibbaro, S; Kremer, S; Lersy, F; Namer, IJ	1
Brixi, H; Cadiot, G; Deguelte, S; Lelièvre, M; Morland, D; Perrier, M; Triumbari, EKA	1
Mohammadi Ghalebin, M; Sadremomtaz, A	1

Reviews

27 review(s) available for fluorodeoxyglucose f18 and dihydroxyphenylalanine

Article	Year
The heritage of radiotracers for positron emission tomography. Acta radiologica. Supplementum, 1990, Volume: 374 Topics: Carbon Radioisotopes; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Metaraminol; Tomography, Emission-Computed	1990
Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome. Movement disorders : official journal of the Movement Disorder Society, 1995, Volume: 10, Issue:4 Topics: Antiparkinson Agents; Blood Glucose; Carbidopa; Contrast Media; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Drug Combinations; Female; Fluorodeoxyglucose F18; Functional Laterality; Hemiplegia; Humans; Levodopa; Middle Aged; Muscle Hypotonia; Muscular Atrophy; Neurologic Examination; Parkinson Disease, Secondary; Physical Exertion; Substantia Nigra; Tomography, Emission-Computed	1995
The role of radiotracer imaging in Parkinson disease. Neurology, 2005, Jan-25, Volume: 64, Issue:2 Topics: Biomarkers; Biotransformation; Blood-Brain Barrier; Carbon Radioisotopes; Clinical Trials as Topic; Cocaine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Humans; Iodine Radioisotopes; Neurons; Parkinson Disease; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Receptors, Dopamine; Substantia Nigra; Tetrabenazine; Tomography, Emission-Computed, Single-Photon	2005
Imaging of pheochromocytoma and paraganglioma. Familial cancer, 2005, Volume: 4, Issue:1 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed	2005
The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast. Seminars in nuclear medicine, 2006, Volume: 36, Issue:1 Topics: Bone Neoplasms; Breast Neoplasms; Choline; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals	2006
[PET and malignant cerebral tumors]. Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Pt 2 Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Methionine; Positron-Emission Tomography; Radiopharmaceuticals	2006
Non-[18F]FDG PET in clinical oncology. The Lancet. Oncology, 2007, Volume: 8, Issue:9 Topics: Antibodies; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Medical Oncology; Neoplasms; Oxygen; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Estrogen; Receptors, Somatostatin	2007
(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Seminars in nuclear medicine, 2007, Volume: 37, Issue:6 Topics: Amino Acids; Animals; Bone and Bones; Cell Hypoxia; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Estradiol; Fluorine Radioisotopes; Fluoroacetates; Fluorodeoxyglucose F18; Glucose; Humans; Membrane Lipids; Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2007
PET imaging of brain tumors. Cancer treatment and research, 2008, Volume: 143 Topics: Biopsy; Brain; Brain Neoplasms; Cell Proliferation; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lipids; Medical Oncology; Methionine; Positron-Emission Tomography; Radiopharmaceuticals; Tyrosine	2008
[Adrenal incidentaloma and nuclear medicine examination]. Journal de radiologie, 2009, Volume: 90, Issue:3 Pt 2 Topics: 19-Iodocholesterol; 3-Iodobenzylguanidine; Adenoma; Adrenal Cortex Neoplasms; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Incidental Findings; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals	2009
PET and PET/CT in endocrine tumours. European journal of radiology, 2010, Volume: 73, Issue:3 Topics: Carbon Radioisotopes; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Image Interpretation, Computer-Assisted; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2010
[Nuclear medicine imaging in patients with Parkinson's syndrome: an update]. Der Nervenarzt, 2010, Volume: 81, Issue:10 Topics: Animals; Brain; Dihydroxyphenylalanine; Disease Progression; Dopamine; Energy Metabolism; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Nerve Degeneration; Neurons; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; Receptors, Dopamine; Regional Blood Flow; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon	2010
Contemporary nuclear medicine imaging of neuroendocrine tumours. Clinical radiology, 2012, Volume: 67, Issue:11 Topics: Chromaffin System; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2012
Nuclear medicine in NET. Wiener medizinische Wochenschrift (1946), 2012, Volume: 162, Issue:19-20 Topics: Biomarkers, Tumor; Cell Proliferation; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Receptors, Peptide; Receptors, Somatostatin; Tomography, X-Ray Computed	2012
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2013, Volume: 194 Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed	2013
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6 Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Lung Neoplasms; Multimodal Imaging; Neoplasm Metastasis; Neuroendocrine Tumors; Octreotide; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Recurrence; Sensitivity and Specificity; Thyroid Neoplasms; Tomography, Emission-Computed, Single-Photon	2013
Bone metastases radiopharmaceuticals: an overview. Current radiopharmaceuticals, 2013, Volume: 6, Issue:1 Topics: 3-Iodobenzylguanidine; Bone Neoplasms; Choline; Dihydroxyphenylalanine; Diphosphonates; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Positron-Emission Tomography; Radioimmunodetection; Radiopharmaceuticals; Sodium Fluoride; Somatostatin; Technetium; Thymidine; Tomography, Emission-Computed, Single-Photon	2013
PET/CT imaging in neuroblastoma. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2013, Volume: 57, Issue:1 Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Central Nervous System Neoplasms; Child; Child, Preschool; Dihydroxyphenylalanine; Ephedrine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Medical Oncology; Models, Biological; Models, Chemical; Neoplasm Staging; Neuroblastoma; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recurrence; Reproducibility of Results; Tomography, X-Ray Computed	2013
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma? Current radiopharmaceuticals, 2013, Jun-06, Volume: 6, Issue:2 Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiation Dosage; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed	2013
Role of (18) F-FDOPA PET/CT imaging in endocrinology. Clinical endocrinology, 2014, Volume: 81, Issue:6 Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Neuroendocrine Tumors; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, X-Ray Computed	2014
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports. Current radiopharmaceuticals, 2014, Volume: 7, Issue:2 Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Surgery, Computer-Assisted; Thyroid Neoplasms; Tomography, Emission-Computed	2014
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes. PET clinics, 2015, Volume: 10, Issue:3 Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gastrointestinal Neoplasms; Humans; Multimodal Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Radiotherapy; Thyroid Neoplasms; Tomography, X-Ray Computed	2015
Pitfalls and Limitations of PET/CT in Brain Imaging. Seminars in nuclear medicine, 2015, Volume: 45, Issue:6 Topics: Amyloid; Artifacts; Brain; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Movement; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed	2015
Role of positron emission tomography imaging in Multiple Endocrine Neoplasia syndromes. Clinical physiology and functional imaging, 2018, Volume: 38, Issue:1 Topics: 5-Hydroxytryptophan; Biomarkers, Tumor; Dihydroxyphenylalanine; Ephedrine; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Methionine; Multiple Endocrine Neoplasia; Mutation; Phenotype; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Receptors, Somatostatin	2018
Nuclear Medicine in Patients with NET: Radiolabeled Somatostatin Analogues and their Brothers. Current radiopharmaceuticals, 2017, Volume: 10, Issue:2 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Somatostatin	2017
Physiopathological Premises to Nuclear Medicine Imaging of Pancreatic Neuroendocrine Tumours. Current radiopharmaceuticals, 2019, Volume: 12, Issue:2 Topics: Animals; Dihydroxyphenylalanine; Dimerization; Edetic Acid; Fluorodeoxyglucose F18; Glucagon-Like Peptide-1 Receptor; Humans; Indium Radioisotopes; Insulinoma; Ligands; Mice; Neuroendocrine Tumors; Nuclear Medicine; Octreotide; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin	2019
Novel PET tracers: added value for endocrine disorders. Endocrine, 2019, Volume: 64, Issue:1 Topics: Dihydroxyphenylalanine; Endocrine System Diseases; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Radiopharmaceuticals	2019

Trials

8 trial(s) available for fluorodeoxyglucose f18 and dihydroxyphenylalanine

Article	Year
Striatal 18F-dopa uptake and brain glucose metabolism by PET in patients with syndrome of progressive ataxia. Journal of the neurological sciences, 1994, Volume: 124, Issue:2 Topics: Adult; Aged; Ataxia; Atrophy; Brain Chemistry; Brain Stem; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neostriatum; Olivopontocerebellar Atrophies; Tomography, Emission-Computed	1994
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. European journal of nuclear medicine, 2001, Volume: 28, Issue:1 Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Receptors, Somatostatin; Thyroid Neoplasms; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results. European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:9 Topics: Adult; Aged; Carcinoma, Small Cell; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed	2003
18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:6 Topics: Adult; Aged; Brain Neoplasms; California; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2006
Basal ganglia involvement in temporal lobe epilepsy: a functional and morphologic study. Neurology, 2008, Jan-15, Volume: 70, Issue:3 Topics: Adolescent; Adult; Basal Ganglia; Basal Ganglia Diseases; Dihydroxyphenylalanine; Dopamine; Down-Regulation; Energy Metabolism; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neostriatum; Neural Pathways; Positron-Emission Tomography; Predictive Value of Tests; Sensitivity and Specificity; Substantia Nigra	2008
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12 Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Ki-67 Antigen; Kinetics; Male; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Positron-Emission Tomography; Prospective Studies; Recurrence; Thyroid Neoplasms; Tomography, X-Ray Computed	2011
18F-FDOPA PET/CT for detection of recurrence in patients with glioma: prospective comparison with 18F-FDG PET/CT. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:7 Topics: Adolescent; Adult; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prospective Studies; Recurrence; Reference Standards; Sensitivity and Specificity; Tomography, X-Ray Computed; Young Adult	2013
Integrated whole-body PET/MRI with 18F-FDG, 18F-FDOPA, and 18F-FDA in paragangliomas in comparison with PET/CT: NIH first clinical experience with a single-injection, dual-modality imaging protocol. Clinical nuclear medicine, 2014, Volume: 39, Issue:3 Topics: Adult; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; National Institutes of Health (U.S.); Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed; United States; Whole Body Imaging	2014

Other Studies

108 other study(ies) available for fluorodeoxyglucose f18 and dihydroxyphenylalanine

Article	Year
Increased striatal 18F-dopa uptake and normal glucose metabolism in idiopathic dystonia syndrome. Journal of the neurological sciences, 1992, Volume: 111, Issue:2 Topics: Adult; Caudate Nucleus; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Dystonia; Dystonia Musculorum Deformans; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Putamen; Tomography, Emission-Computed; Torticollis	1992
Positron emission tomography in degenerative disorders of the dopaminergic system. Journal of neural transmission. Parkinson's disease and dementia section, 1992, Volume: 4, Issue:2 Topics: Adult; Aged; Alzheimer Disease; Basal Ganglia; Brain; Brain Stem; Deoxyglucose; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Parkinson Disease; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	1992
Absorbed dose estimates in positron emission tomography studies based on the administration of 18F-labeled radiopharmaceuticals. Journal of radiation research, 1991, Volume: 32, Issue:3 Topics: Adult; Animals; Deoxyglucose; Dihydroxyphenylalanine; Dogs; Floxuridine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Mice; Middle Aged; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed, Single-Photon	1991
Normal aging of the nervous system. Annals of neurology, 1991, Volume: 30, Issue:2 Topics: Aging; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Nervous System Physiological Phenomena; Reference Values	1991
The metabolic anatomy of Parkinson's disease: complementary [18F]fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies. Movement disorders : official journal of the Movement Disorder Society, 1990, Volume: 5, Issue:3 Topics: Adult; Brain; Deoxy Sugars; Deoxyglucose; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Tomography, Emission-Computed	1990
Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism. Advances in neurology, 1987, Volume: 45 Topics: Adult; Aged; Blood Glucose; Brain; Caudate Nucleus; Cerebellum; Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Levodopa; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed	1987
Complementary positron emission tomographic studies of the striatal dopaminergic system in Parkinson's disease. Archives of neurology, 1995, Volume: 52, Issue:12 Topics: Adult; Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Deoxyglucose; Dihydroxyphenylalanine; Dopa Decarboxylase; Dopamine; Dopamine Antagonists; Energy Metabolism; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Salicylamides; Tomography, Emission-Computed	1995
Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome. Neurology, 1994, Volume: 44, Issue:9 Topics: Adult; Atrophy; Brain; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Syndrome; Tomography, Emission-Computed	1994
An interactive technique for three-dimensional image registration: validation for PET, SPECT, MRI and CT brain studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:12 Topics: Brain; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Software; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed	1994
Secondary parkinsonism due to focal substantia nigra lesions: a PET study with [18F]FDG and [18F]fluorodopa. Acta neurologica Scandinavica, 1996, Volume: 93, Issue:6 Topics: Aged; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Substantia Nigra; Tomography, Emission-Computed	1996
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration. Journal of the neurological sciences, 1996, Volume: 139, Issue:2 Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed	1996
Chemical reactivity of the 18F electrophilic reagents from the 18O(p,n) 18F gas target systems. Nuclear medicine and biology, 1996, Volume: 23, Issue:5 Topics: Aluminum; Copper; Deoxyglucose; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gases; Gold; Isotope Labeling; Magnetic Resonance Spectroscopy; Metals; Nickel; Oxygen Isotopes; Silver	1996
[A case of familial juvenile dystonia-parkinsonism: 18F-6-fluorodopa and 18F-fluoro-2-deoxyglucose PET study]. Rinsho shinkeigaku = Clinical neurology, 1996, Volume: 36, Issue:5 Topics: Adult; Age of Onset; Brain; Deoxyglucose; Dihydroxyphenylalanine; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Levodopa; Parkinson Disease; Tomography, Emission-Computed	1996
F-Dopa as an amino acid tracer to detect brain tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:7 Topics: Brain; Brain Neoplasms; Deoxyglucose; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glioma; Glucose; Humans; Magnetic Resonance Imaging; Methionine; Middle Aged; Oxygen Radioisotopes; Tomography, Emission-Computed; Water	1996
Regional changes in [18F]dopa metabolism in the striatum in Parkinson's disease. Brain : a journal of neurology, 1996, Volume: 119 ( Pt 6) Topics: Deoxyglucose; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Middle Aged; Parkinson Disease; Putamen; Tomography, Emission-Computed	1996
Differentiating between multiple system atrophy and Parkinson's disease by positron emission tomography with 18F-dopa and 18F-FDG. Annals of nuclear medicine, 1997, Volume: 11, Issue:3 Topics: Adult; Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Tomography, Emission-Computed	1997
Striatal dopamine metabolism correlated with frontotemporal glucose utilization in Alzheimer's disease: a double-tracer PET study. Neurology, 1997, Volume: 49, Issue:4 Topics: Aged; Alzheimer Disease; Brain; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Humans; Male; Radiopharmaceuticals; Temporal Lobe; Tissue Distribution; Tomography, Emission-Computed	1997
Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. Brain : a journal of neurology, 1997, Volume: 120 ( Pt 12) Topics: Aged; Carbon Radioisotopes; Caudate Nucleus; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Hypotension, Orthostatic; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Putamen; Raclopride; Radiography; Radiopharmaceuticals; Receptors, Dopamine D2; Regression Analysis; Salicylamides; Tomography, Emission-Computed	1997
Nervous system dysfunction in Waldenström's macroglobulinemia: response to treatment. Neurology, 1998, Volume: 51, Issue:4 Topics: Antibodies, Monoclonal; Bone Marrow Transplantation; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Immunoglobulin M; Male; Middle Aged; Myelin-Associated Glycoprotein; Neural Conduction; Parkinson Disease, Secondary; Peripheral Nervous System Diseases; Tomography, Emission-Computed; Waldenstrom Macroglobulinemia	1998
Positron emission tomographic studies in restless legs syndrome. Movement disorders : official journal of the Movement Disorder Society, 1999, Volume: 14, Issue:1 Topics: Aged; Brain; Dihydroxyphenylalanine; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Receptors, Dopamine; Receptors, Presynaptic; Restless Legs Syndrome; Tomography, Emission-Computed	1999
Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. Journal of neurology, 1999, Volume: 246, Issue:12 Topics: Aged; Basal Ganglia; Brain Diseases; Cerebral Cortex; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Radiopharmaceuticals; Reference Values; Tissue Distribution; Tomography, Emission-Computed	1999
Putaminal necrosis presenting with hemidystonia. Pediatric neurology, 2000, Volume: 22, Issue:3 Topics: Antiparkinson Agents; Brain Diseases; Child; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Dystonia; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Levodopa; Magnetic Resonance Imaging; Necrosis; Putamen; Tomography, Emission-Computed; Treatment Outcome	2000
FDG- and Dopa-PET in postencephalitic parkinsonism. Journal of neural transmission (Vienna, Austria : 1996), 2000, Volume: 107, Issue:11 Topics: Aged; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Parkinson Disease; Parkinson Disease, Postencephalitic; Radiopharmaceuticals; Reference Values; Tomography, Emission-Computed	2000
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Models, Theoretical; Oxygen Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed	2001
Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2001, Volume: 42, Issue:2 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed	2001
Whole-body 18F dopa PET for detection of gastrointestinal carcinoid tumors. Radiology, 2001, Volume: 220, Issue:2 Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Lymphatic Metastasis; Magnetic Resonance Imaging; Male; Middle Aged; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET. Journal of neural transmission (Vienna, Austria : 1996), 2001, Volume: 108, Issue:6 Topics: Adult; Brain; Chronic Disease; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Neural Pathways; Radiopharmaceuticals; Schizophrenia, Catatonic; Speech; Tomography, Emission-Computed	2001
Functional decline in Parkinson disease. Archives of neurology, 2001, Volume: 58, Issue:10 Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Autonomic Nervous System Diseases; Demography; Dihydroxyphenylalanine; Disease Progression; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Multiple System Atrophy; Multivariate Analysis; Neurologic Examination; Parkinson Disease; Radiopharmaceuticals; Time Factors	2001
Fluoro-DOPA and FDG positron emission tomography in a case of pathologically verified pure diffuse Lewy body disease. Journal of neurology, 2001, Volume: 248, Issue:10 Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, X-Ray Computed	2001
Familial progressive supranuclear palsy: detection of subclinical cases using 18F-dopa and 18fluorodeoxyglucose positron emission tomography. Archives of neurology, 2001, Volume: 58, Issue:11 Topics: Adult; Aged; Caudate Nucleus; Dihydroxyphenylalanine; Dopamine Agents; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Pedigree; Putamen; Radiopharmaceuticals; Supranuclear Palsy, Progressive; Tomography, Emission-Computed	2001
Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study. Movement disorders : official journal of the Movement Disorder Society, 2002, Volume: 17, Issue:4 Topics: Adult; Aged; Brain; Cerebellum; Dihydroxyphenylalanine; Dominance, Cerebral; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Parkinson Disease; Putamen; Raclopride; Receptors, Dopamine D2; Reference Values; Tomography, Emission-Computed; Tremor; Up-Regulation	2002
Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. NeuroImage, 2004, Volume: 22, Issue:2 Topics: Biological Transport; Brain; Brain Mapping; Cognition; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Motor Activity; Parkinson Disease; Radiopharmaceuticals; Regression Analysis; Tomography, Emission-Computed	2004
F-18 FDG and F-18 FDOPA PET brain imaging in subacute sclerosing panencephalitis. Clinical nuclear medicine, 2005, Volume: 30, Issue:7 Topics: Adult; Brain; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Subacute Sclerosing Panencephalitis	2005
Corticostriatal covariance patterns of 6-[18F]fluoro-L-dopa and [18F]fluorodeoxyglucose PET in Parkinson's disease. Journal of neurology, 2006, Volume: 253, Issue:3 Topics: Aged; Cerebral Cortex; Corpus Striatum; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Functional Laterality; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Sex Factors	2006
Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:7 Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms	2006
Striatal dopa and glucose metabolism in PD patients with freezing of gait. Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:9 Topics: Blood Glucose; Brain Mapping; Corpus Striatum; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Gait Apraxia; Humans; Male; Neurologic Examination; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Putamen	2006
Comparative assessment of statistical brain MR image segmentation algorithms and their impact on partial volume correction in PET. NeuroImage, 2006, Oct-01, Volume: 32, Issue:4 Topics: Algorithms; Brain; Brain Mapping; Data Interpretation, Statistical; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2006
18F-DOPA PET/CT and neuroendocrine tumours. European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:5 Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed	2006
Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. The Lancet. Oncology, 2006, Volume: 7, Issue:9 Topics: Adult; Aged; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Receptors, Somatostatin; Reproducibility of Results; Somatostatin; Tomography, X-Ray Computed	2006
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma. European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:10 Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thyroid Neoplasms	2007
The use of 18-fluoro-dihydroxyphenylalanine and 18-fluorodeoxyglucose positron emission tomography scanning in the assessment of metaiodobenzylguanidine-negative phaeochromocytoma. European journal of endocrinology, 2007, Volume: 157, Issue:4 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Whole Body Imaging	2007
Biomarkers to detect central dopamine deficiency and distinguish Parkinson disease from multiple system atrophy. Parkinsonism & related disorders, 2008, Volume: 14, Issue:8 Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Biomarkers; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Septum; Humans; Male; Multiple System Atrophy; Parkinson Disease; Positron-Emission Tomography; Sensitivity and Specificity	2008
Improved staging of patients with carcinoid and islet cell tumors with 18F-dihydroxy-phenyl-alanine and 11C-5-hydroxy-tryptophan positron emission tomography. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Mar-20, Volume: 26, Issue:9 Topics: 5-Hydroxytryptophan; Adenoma, Islet Cell; Adult; Aged; Carbon Radioisotopes; Carcinoid Tumor; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Somatostatin; Sensitivity and Specificity; Tomography, X-Ray Computed	2008
The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas. Clinical endocrinology, 2008, Volume: 69, Issue:4 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasms, Multiple Primary; Pheochromocytoma; Positron-Emission Tomography; Retrospective Studies; Tomography, Emission-Computed, Single-Photon	2008
[18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism]. Anales de pediatria (Barcelona, Spain : 2003), 2008, Volume: 68, Issue:5 Topics: ATP-Binding Cassette Transporters; Congenital Hyperinsulinism; Dihydroxyphenylalanine; DNA Mutational Analysis; Fluorodeoxyglucose F18; Growth Hormone; Humans; Infant; Male; Pancreas; Point Mutation; Positron-Emission Tomography; Potassium Channels, Inwardly Rectifying; Radiopharmaceuticals; Receptors, Drug; Severity of Illness Index; Sulfonylurea Receptors; Tomography, X-Ray Computed	2008
Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography. Circulation, 2008, Oct-07, Volume: 118, Issue:15 Topics: Carcinoid Heart Disease; Carcinoid Tumor; Dihydroxyphenylalanine; Dopamine Agents; Fluorodeoxyglucose F18; Heart Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2008
Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:4 Topics: Adult; Biopsy; Carcinoid Tumor; Dihydroxyphenylalanine; Endocrine Gland Neoplasms; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Humans; Ileal Neoplasms; Neoplasm Metastasis; Positron-Emission Tomography	2009
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT. European radiology, 2009, Volume: 19, Issue:6 Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Thyroid Neoplasms; Tomography, X-Ray Computed	2009
Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients. European journal of cancer (Oxford, England : 1990), 2009, Volume: 45, Issue:13 Topics: Adenocarcinoma; Aged; Carcinoid Tumor; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Rectal Neoplasms; Tomography, X-Ray Computed	2009
Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:12 Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2009
Striatal "function-metabolism" mismatch on F-18 FDG/F-18 FDOPA PET/CT. Clinical nuclear medicine, 2009, Volume: 34, Issue:10 Topics: Corpus Striatum; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Injections, Intravenous; Male; Middle Aged; Oligodendroglioma; Positron-Emission Tomography; Tomography, X-Ray Computed	2009
The test-retest reliability of 18F-DOPA PET in assessing striatal and extrastriatal presynaptic dopaminergic function. NeuroImage, 2010, Apr-01, Volume: 50, Issue:2 Topics: Adult; Brain; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Presynaptic Terminals; Radiopharmaceuticals; Reproducibility of Results; Young Adult	2010
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2010, Volume: 36, Issue:4 Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiography; Radiopharmaceuticals; Sensitivity and Specificity; Statistics, Nonparametric; Thyroid Neoplasms; Thyroidectomy	2010
The use of functional imaging in a patient with head and neck paragangliomas. The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:2 Topics: Adult; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Comparative evaluation of F-18 FDOPA, F-18 FDG, and F-18 FLT-PET/CT for metabolic imaging of low grade gliomas. Clinical nuclear medicine, 2009, Volume: 34, Issue:12 Topics: Adolescent; Adult; Brain Neoplasms; Child; Child, Preschool; Dideoxynucleosides; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed; Young Adult	2009
Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology, 2010, Mar-16, Volume: 74, Issue:11 Topics: Acetylcholine; Aged; Brain; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lewy Bodies; Lewy Body Disease; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2010
Diagnosis: imaging of pheochromocytomas and paragangliomas. Nature reviews. Endocrinology, 2010, Volume: 6, Issue:4 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Contrast Media; Diagnostic Imaging; Dihydroxyphenylalanine; Evaluation Studies as Topic; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography; Tomography, X-Ray Computed	2010
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT. Clinical nuclear medicine, 2010, Volume: 35, Issue:6 Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hemangioma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Thyroid Neoplasms; Tomography, X-Ray Computed	2010
Gaucher disease ascertained through a Parkinson's center: imaging and clinical characterization. Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-30, Volume: 25, Issue:10 Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gaucher Disease; Glucosylceramidase; Humans; Male; Middle Aged; Mutation; Neuropsychological Tests; Olfaction Disorders; Parkinson Disease; Phenotype; Positron-Emission Tomography; Ultrasonography, Doppler, Transcranial	2010
Metabolic imaging allows early prediction of response to vandetanib. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:2 Topics: Aged; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Dihydroxyphenylalanine; Down-Regulation; Female; Fluorodeoxyglucose F18; G1 Phase; Glucose; Humans; Male; Mice; Mice, SCID; Microarray Analysis; Piperidines; Positron-Emission Tomography; Proto-Oncogene Proteins c-ret; Quality Control; Quinazolines; Radiopharmaceuticals; Resting Phase, Cell Cycle; RNA, Neoplasm; Signal Transduction; Thymidine; Thyroid Neoplasms; Tomography, Emission-Computed	2011
Functional imaging of neuroendocrine tumors. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: 5-Hydroxytryptophan; Animals; Contrast Media; Dihydroxyphenylalanine; Dopamine; Ephedrine; Etomidate; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Peptides; Positron-Emission Tomography; Radioactive Tracers; Radiopharmaceuticals; Somatostatin	2011
Pancreatic and hepatobiliary cancers. Methods in molecular biology (Clifton, N.J.), 2011, Volume: 727 Topics: Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Middle Aged; Octreotide; Organometallic Compounds; Pancreas; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals	2011
Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:9 Topics: 3-Iodobenzylguanidine; Adult; Brain Mapping; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Male; Middle Aged; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Somatostatin; Succinate Dehydrogenase; Tomography, Emission-Computed	2011
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gallium Radioisotopes; Humans; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Precision Medicine; Recurrence; Retrospective Studies; Somatostatin; Thyroid Neoplasms; Tomography, X-Ray Computed	2012
Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity. The Journal of clinical endocrinology and metabolism, 2012, Volume: 97, Issue:6 Topics: Adult; Carbon Radioisotopes; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gastric Bypass; Humans; Hyperinsulinism; Hypoglycemia; Nesidioblastosis; Obesity, Morbid; Positron-Emission Tomography; Postoperative Complications	2012
Head-to-head comparison between SRS, (18)F-FDG and (18)F-FDOPA PET/CT in a patient with recurrent SDHC-related jugular paraganglioma. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:10 Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Membrane Proteins; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Paraganglioma; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Recurrent glioma and crossed cerebellar diaschisis in a patient examined with 18F-DOPA and 18F-FDG PET/CT. Clinical nuclear medicine, 2012, Volume: 37, Issue:9 Topics: Cerebellar Diseases; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Middle Aged; Radionuclide Imaging; Recurrence	2012
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12 Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Recurrence; Retrospective Studies; Survival Analysis; Thyroid Neoplasms; Young Adult	2012
Nature or nurture? Determining the heritability of human striatal dopamine function: an [18F]-DOPA PET study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2013, Volume: 38, Issue:3 Topics: Adult; Cohort Studies; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Social Environment; Twins, Dizygotic; Twins, Monozygotic	2013
Characterization of neuroblastic tumors using 18F-FDOPA PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:1 Topics: 3-Iodobenzylguanidine; Biological Transport; Carboxy-Lyases; Catecholamines; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Gene Expression Regulation, Neoplastic; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity; Vanilmandelic Acid	2013
Multifocal extra-adrenal paraganglioma evaluated with different PET tracers: comparison between 18F-FDG, 18F-DOPA and 68Ga DOTANOC PET/CT. Clinical nuclear medicine, 2013, Volume: 38, Issue:12 Topics: Adult; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Multimodal Imaging; Organometallic Compounds; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radioactive Tracers; Tomography, X-Ray Computed	2013
Topographic diagnosis: respective roles of morphological and functional imaging. Annales d'endocrinologie, 2013, Volume: 74, Issue:3 Topics: 5-Hydroxytryptophan; Anatomy, Cross-Sectional; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemia; Imaging, Three-Dimensional; Insulinoma; Magnetic Resonance Imaging; Pancreatic Neoplasms; Practice Guidelines as Topic; Receptors, Glucagon; Receptors, Somatostatin	2013
Observations on the effects of lithium on carcinoid tumors. Pancreas, 2013, Volume: 42, Issue:6 Topics: Bone Neoplasms; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Lithium Compounds; Liver Neoplasms; Male; Mood Disorders; Positron-Emission Tomography; Reproducibility of Results; Sensitivity and Specificity; Young Adult	2013
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:12 Topics: Adrenal Gland Neoplasms; Aged; Biological Transport; Bone Neoplasms; Dideoxynucleosides; Dihydroxyphenylalanine; Dopamine; Fluorodeoxyglucose F18; Humans; Male; Paraganglioma; Positron-Emission Tomography; Radioactive Tracers	2013
Comparison of visual and semiquantitative analysis of 18F-FDOPA-PET/CT for recurrence detection in glioblastoma patients. Neuro-oncology, 2014, Volume: 16, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioblastoma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tomography, X-Ray Computed; Young Adult	2014
Parkinson's disease subtypes show a specific link between dopaminergic and glucose metabolism in the striatum. PloS one, 2014, Volume: 9, Issue:5 Topics: Aged; Dihydroxyphenylalanine; Dopamine; Dopaminergic Neurons; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Ventral Striatum	2014
Renaissance of (18)F-FDG positron emission tomography in the imaging of pheochromocytoma/paraganglioma. The Journal of clinical endocrinology and metabolism, 2014, Volume: 99, Issue:7 Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; History, 20th Century; History, 21st Century; Humans; Paraganglioma; Pheochromocytoma; Positron-Emission Tomography	2014
Fetal and maternal absorbed dose estimates for positron-emitting molecular imaging probes. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2014, Volume: 55, Issue:9 Topics: Dihydroxyphenylalanine; Female; Fetus; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Pheochromocytoma; Positron-Emission Tomography; Pregnancy; Radiation Dosage	2014
Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad. Clinical nuclear medicine, 2015, Volume: 40, Issue:1 Topics: Adult; Chondroma; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Multimodal Imaging; Paraganglioma, Extra-Adrenal; Positron-Emission Tomography; Radiopharmaceuticals; Stomach Neoplasms; Tomography, X-Ray Computed	2015
Functional imaging in neurodegenerative disorders: past, present and future. The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of..., 2014, Volume: 58, Issue:4 Topics: Cognition Disorders; Diagnostic Imaging; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neurodegenerative Diseases; Positron-Emission Tomography	2014
18F-DOPA vs. 18F-FDG PET/CT in the ectopic ACTH syndrome due to pulmonary carcinoid tumor. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2015, Volume: 62, Issue:4 Topics: ACTH Syndrome, Ectopic; Adult; Carcinoid Tumor; Dihydroxyphenylalanine; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Male; Pituitary ACTH Hypersecretion; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2015
The role of 18FDG, 18FDOPA PET/CT and 99mTc bone scintigraphy imaging in Erdheim-Chester disease. European journal of radiology, 2015, Volume: 84, Issue:8 Topics: Adult; Aged; Bone and Bones; Dihydroxyphenylalanine; Erdheim-Chester Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Technetium; Tomography, X-Ray Computed	2015
The Role of PET [18F]FDOPA in Evaluating Low-grade Glioma. Anticancer research, 2015, Volume: 35, Issue:9 Topics: Adult; Aged; Brain Neoplasms; Demography; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glioma; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; ROC Curve; Young Adult	2015
Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study. Neuro-oncology, 2015, Volume: 17, Issue:12 Topics: Adolescent; Brain; Child; Child, Preschool; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Glioma; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prognosis; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Sensitivity and Specificity; Supratentorial Neoplasms	2015
Weak uptake of 123I-MIBG and 18F-FDOPA contrasting with high 18F-FDG uptake in stage I neuroblastoma. Clinical nuclear medicine, 2015, Volume: 40, Issue:12 Topics: 3-Iodobenzylguanidine; Brain Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron-Emission Tomography; Radiopharmaceuticals	2015
68Ga-DOTATATE PET/CT in the Localization of Head and Neck Paragangliomas Compared with Other Functional Imaging Modalities and CT/MRI. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Adult; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Organometallic Compounds; Paraganglioma; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Succinate Dehydrogenase; Tomography, X-Ray Computed	2016
Putaminal dopamine turnover in de novo Parkinson disease predicts later motor complications. Neurology, 2016, Jan-19, Volume: 86, Issue:3 Topics: Aged; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Dyskinesias; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Putamen; Single-Blind Method	2016
18F-DOPA Uptake of Developmental Venous Anomalies in Children With Brain Tumors. Clinical nuclear medicine, 2016, Volume: 41, Issue:7 Topics: Brain; Brain Neoplasms; Child; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals	2016
Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. Oncotarget, 2016, Apr-05, Volume: 7, Issue:14 Topics: Cohort Studies; Dihydroxyphenylalanine; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genomics; Humans; Infant; Male; Neuroblastoma; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Treatment Outcome	2016
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies. Parkinsonism & related disorders, 2016, Volume: 31 Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats	2016
Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy. Clinical nuclear medicine, 2017, Volume: 42, Issue:1 Topics: 3-Iodobenzylguanidine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Neoplasms, Multiple Primary; Octreotide; Organometallic Compounds; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Risk Stratification of Pediatric Patients With Neuroblastoma Using Volumetric Parameters of 18F-FDG and 18F-DOPA PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:3 Topics: Adolescent; Child; Child, Preschool; Cone-Beam Computed Tomography; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Infant; Lymphatic Metastasis; Male; Neuroblastoma; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals	2017
Recurrent Scapular Metastasis From Hepatoblastoma Shown on FDG PET/CT and F-DOPA PET/CT. Clinical nuclear medicine, 2017, Volume: 42, Issue:10 Topics: Bone Neoplasms; Child; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Hepatoblastoma; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence; Scapula	2017
Movement disorders : official journal of the Movement Disorder Society, 2018, Volume: 33, Issue:1 Topics: Brain; Brain Mapping; Dihydroxyphenylalanine; Disease Progression; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Nortropanes; Parkinson Disease; Positron-Emission Tomography; Severity of Illness Index	2018
The mean striatal European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:5 Topics: Amino Acids; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma; Humans; Positron-Emission Tomography; Tumor Burden	2019
Covariance statistics and network analysis of brain PET imaging studies. Scientific reports, 2019, 02-21, Volume: 9, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cross-Sectional Studies; Dihydroxyphenylalanine; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals	2019
18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma. Clinical nuclear medicine, 2019, Volume: 44, Issue:9 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Pheochromocytoma; Positron Emission Tomography Computed Tomography; Sensitivity and Specificity; Young Adult	2019
Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI. Nuklearmedizin. Nuclear medicine, 2019, Volume: 58, Issue:5 Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Time Factors	2019
Network degeneration in Parkinson's disease: multimodal imaging of nigro-striato-cortical dysfunction. Brain : a journal of neurology, 2020, 03-01, Volume: 143, Issue:3 Topics: Aged; Case-Control Studies; Cerebral Cortex; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neural Pathways; Parkinson Disease; Positron-Emission Tomography; Putamen; Substantia Nigra	2020
Metabolic Evolution of Brain Metastasis After Stereotactic Radiosurgery: Mismatch Between F-DOPA and FDG PET. Clinical nuclear medicine, 2020, Volume: 45, Issue:7 Topics: Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Radiation-Induced; Positron-Emission Tomography; Radiosurgery	2020
Deep learning-guided joint attenuation and scatter correction in multitracer neuroimaging studies. Human brain mapping, 2020, Volume: 41, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Benzothiazoles; Carbolines; Cognitive Dysfunction; Deep Learning; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2020
Hemispheric Network Expression in Parkinson's Disease: Relationship to Dopaminergic Asymmetries. Journal of Parkinson's disease, 2020, Volume: 10, Issue:4 Topics: Aged; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography	2020
Diagnosis of Ectopic Pancreas in Small Intestine With 18F-DOPA PET/CT. Clinical nuclear medicine, 2021, Dec-01, Volume: 46, Issue:12 Topics: Aged; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Intestine, Small; Male; Pancreas; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography	2021
Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging. Clinical nuclear medicine, 2022, Mar-01, Volume: 47, Issue:3 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Aged; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Iodine Radioisotopes; Mutation; Octreotide; Organometallic Compounds; Pheochromocytoma; Positron Emission Tomography Computed Tomography	2022
Prognostic Value of Interim 18F-DOPA and 18F-FDG PET/CT Findings in Stage 3-4 Pediatric Neuroblastoma. Clinical nuclear medicine, 2022, Jan-01, Volume: 47, Issue:1 Topics: Child; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroblastoma; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies	2022
18 F-FDOPA and MRI Findings in a Case of Multiple Sclerosis. Clinical nuclear medicine, 2022, 11-01, Volume: 47, Issue:11 Topics: Adult; Brain Neoplasms; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2022
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factors. Endocrine, 2022, Volume: 78, Issue:2 Topics: Bone Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Neuroendocrine Tumors; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Risk Factors	2022
Dose evaluation of the one-year-old child in PET imaging by Biomedical physics & engineering express, 2023, 02-23, Volume: 9, Issue:2 Topics: Child; Dihydroxyphenylalanine; Edetic Acid; Fluorodeoxyglucose F18; Humans; Infant; Positron-Emission Tomography	2023